Health Startups Hawking Weight Loss Drugs With Little Oversight

P.M. Edition for Feb. 17. Digital health startups are cashing in on booming demand for a class of diabetes drugs shown to be effective for losing weight. These telemedicine companies appear to be prescribing the drugs with little oversight, and to people who aren't even overweight, an analysis by the Wall Street Journal has found. Digital health reporter Rolfe Winkler joins host Annmarie Fertoli to discuss.  Learn more about your ad choices. Visit megaphone.fm/adchoices